Nova Leah, a platform which helps manufacturers meet cybersecurity requirements, has reportedly raised €2.25m in funding.
The round was led by Bank of Ireland Kernel Capital Growth Fund, through a €1.5m investment into the company, according to a handful of reports in the media. Participation to the round also came from Suir Valley Ventures.
Through the new line of funding, Nova will be looking to further the expansion of its operations, they report.
Ireland-based Nova offers automated cybersecurity for medical devices ensuring that compliance is met across all products. The platform provides 24/7 vulnerability monitoring with real-time repository updates identifying any developing risks. It also offers streamline testing and maintenance, information sharing and cost reduction through automated risk analysis.
Nova’s SelectEvidence solution is able to evolve with cyber threats. It does this through its intelligent risk analysis and treatment, continuous vulnerability analysis, device-specific analysis, real-time repository updates, functional test plan generation, automated compliance reporting and verification traceability reporting.
Earlier in the year, Kernel Capital backed the regulatory compliance service provider Datactis for an undisclosed amount. The Irish company builds a range of software which profile, cleanse, score and match information for data quality and regulatory compliance.
Last year, investor deployed €2.1m into Irish financial risk intelligence company Corlytics. The company implements data analytics technology to help financial institutions minimise the regulatory breaches and avoid fines.
Copyright © 2018 RegTech Analyst
